Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome

被引:0
|
作者
Kyeong Ho Yun
Myung Ho Jeong
Seok Kyu Oh
Sang Jae Rhee
Eun Mi Park
Eun Mi Lee
Nam Jin Yoo
Nam-Ho Kim
Young Keun Ahn
Jin-Won Jeong
机构
[1] Wonkwang University Hospital,Department of Cardiovascular Medicine
[2] Chonnam National University Hospital,Department of Cardiovascular Medicine
来源
Heart and Vessels | 2009年 / 24卷
关键词
Percutaneous coronary angioplasty; Stent; C-reactive protein; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Percutaneous coronary intervention (PCI) provokes an inflammatory reaction, as shown by increased concentrations of plasma C-reactive protein (CRP) after PCI. However, the changes of CRP levels after PCI in patients with acute coronary syndrome (ACS) have not been well evaluated. We evaluated the characteristics of the patients with elevated CRP response after PCI and whether an increase in CRP after PCI predicts long-term prognosis in patients with ACS. We studied consecutive 360 patients with ACS who underwent elective coronary stenting. Inflammatory response to PCI was calculated as the difference between the peak postprocedural hsCRP level and the preprocedural hsCRP level (ΔCRP). Twelve months follow-up data were obtained and clinical outcomes were compared with ΔCRP. In receiver operating characteristics analyses, the cutoff point of ΔCRP for major adverse cardiac events (MACE) was 3.0 mg/l, which yielded sensitivity of 61.7% and specificity of 69.7%. The patients with ΔCRP > 3 mg/l revealed higher incidence of myocardial infarction (37.7 vs 14.6%, P < 0.001), and ACC/AHA type B2/C lesion (81.5 vs 68.7%, P = 0.006) than in patients with low ΔCRP. White blood cell count, low-density lipoprotein cholesterol, peak creatinine kinase-MB, and peak troponin T were significantly elevated in patients with ΔCRP > 3 mg/l than in those with ≤3 mg/l. There was significant correlation between ΔCRP and the changes in troponin T after PCI (r = 0.210, P < 0.001). An increase in hsCRP > 3 mg/l after PCI had a higher predictive value for the occurrence of MACE than low hsCRP elevation (hazard ratio 2.1, P = 0.005). In multivariate analysis, ΔCRP and peak troponin T were independent predictors of MACE (P < 0.001 and P = 0.013, respectively). In conclusion, postprocedural hsCRP elevation >3 mg/l was associated with higher incidence of MACE in patients with ACS. ΔCRP determinations may be of value for risk stratification after PCI.
引用
收藏
页码:175 / 180
页数:5
相关论文
共 50 条
  • [31] Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin
    Luo, YM
    Jiang, DQ
    Wen, D
    Yang, JX
    Li, LY
    HEART AND VESSELS, 2004, 19 (06) : 257 - 262
  • [32] Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin
    Yumei Luo
    Deqian Jiang
    Dan Wen
    Jianxin Yang
    Liying Li
    Heart and Vessels, 2004, 19 : 257 - 262
  • [33] High-sensitivity C-reactive protein in children at risk for coronary artery disease
    Guran, Omer
    Akalin, Figen
    Ayabakan, Canan
    Dereli, Feyza Yagmur
    Haklar, Goncagul
    ACTA PAEDIATRICA, 2007, 96 (08) : 1214 - 1219
  • [34] Relation Between High-Sensitivity C-Reactive Protein and Coronary Plaque Components in Patients With Acute Coronary Syndrome: Virtual Histology-Intravascular Ultrasound Analysis
    Hong, Young Joon
    Jeong, Myung Ho
    Choi, Yun Ha
    Cho, Suk Hee
    Hwang, Seung Hwan
    Ko, Jum Suk
    Lee, Min Goo
    Park, Keun Ho
    Sim, Doo Sun
    Yoon, Nam Sik
    Yoon, Hyun Ju
    Kim, Kye Hun
    Park, Hyung Wook
    Kim, Ju Han
    Ahn, Youngkeun
    Cho, Jeong Gwan
    Park, Jong Chun
    Kang, Jung Chaee
    KOREAN CIRCULATION JOURNAL, 2011, 41 (08) : 440 - 446
  • [35] Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention
    Delhaye, Cedric
    Sudre, Arnaud
    Lemesle, Gilles
    Marechaux, Sylvestre
    Broucqsault, Damien
    Hennache, Bernadette
    Bauters, Christophe
    Lablanche, Jean-Marc
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2009, 10 (03) : 144 - 150
  • [36] The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients
    Fabijanic, Darnir
    Banic, Marko
    Kardum, Dusko
    Sutlic, Zeljko
    Simunic, Miroslav
    Bonacin, Damir
    Romic, Zeljko
    Petricusic, Lidija
    Kujundzic, Milan
    MEDICAL SCIENCE MONITOR, 2009, 15 (02): : CR45 - CR50
  • [37] Comparison of high-sensitivity C-reactive protein level between systemic and coronary circulation in patients with acute myocardial infarction
    Meng, Haoyu
    Zhang, Min
    Chen, Pengsheng
    Wang, Ze-Mu
    Chen, Bo
    Yang, Zhijian
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 46 (02) : 161 - 162
  • [38] High-Sensitivity C-Reactive Protein Combined with Low-Density Lipoprotein Cholesterol as the Targets of Statin Therapy in Patients with Acute Coronary Syndrome
    Fang, Ming
    Qian, Qiaohui
    Zhao, Zhihong
    Zhu, Luoning
    Su, Jinwen
    Li, Xinming
    INTERNATIONAL HEART JOURNAL, 2018, 59 (02) : 300 - 306
  • [39] Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatment
    Riedel, Melanie
    Lafitte, Marianne
    Pucheu, Yann
    Latry, Karin
    Couffinhal, Thierry
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (05) : 1128 - 1137
  • [40] OX40 Ligand Levels and High-sensitivity C-reactive Protein Levels in Blood from Local Coronary Plaque and the Femoral Artery in Patients with Acute Coronary Syndrome or Stable Angina
    Shi, J. Z.
    Wang, L. Y.
    Zhu, Y.
    Zhao, C. Y.
    Liu, W.
    Jiang, S. L.
    You, H. W.
    Wang, Y.
    Xu, F. Y.
    Tang, Y. S.
    Cui, L. Q.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (04) : 1275 - 1283